Cryo-Cell IntlCCEL
13F holders, Q1 2026 (March 31)11holders −6
0new positions
7sold out
$3.55avg. 13F price*
At the end of Q1 2026, 11 institutions reported holding Cryo-Cell Intl Inc. (CCEL) in their 13F filings, down 6 from Q4 2025. 0 opened new positions and 7 sold out. The largest holders were SFI Advisors, LLC ($587K), Vanguard Capital Management LLC ($573K) and MassMutual Private Wealth & Trust, FSB ($394K).
- Company
- Cryo-Cell Intl Inc.
- CUSIP
- 228895108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 7 | $1.6M |
All 13F filers, Q4 2025 → Q1 2026: 1,577 shares bought and 485,656 shares sold, net −484,079 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| SFI Advisors, LLC | 0.62% | No change | 165,300 | $587K |
| Vanguard Capital Management LLC | 0.00% | — | 161,524 | $573K |
| MassMutual Private Wealth & Trust, FSB | 0.01% | No change | 111,035 | $394K |
| Geode Capital Management, LLC | 0.00% | Reduce -18.0% | 43,616 | $155K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 23,346 | $83K |
| BlackRock, Inc. | 0.00% | Add +8.7% | 13,983 | $50K |
| Susquehanna International Group, LLP | 0.00% | Reduce -18.2% | 10,018 | $36K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,500 | $9K |
| UBS Group AG | 0.00% | Add +215.5% | 672 | $2K |
| Morgan Stanley | 0.00% | No change | 601 | $2K |
| Signaturefd, LLC | 0.00% | No change | 100 | $355 |
"% of holder's portfolio" is CCEL's weight in each manager's 13F, not the share of Cryo-Cell Intl Inc. the manager owns.